Detalles de la búsqueda
1.
Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease.
BMC Med
; 18(1): 362, 2020 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33239013
2.
Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study.
Lancet Gastroenterol Hepatol
; 8(5): 446-457, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36898393
3.
Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease.
Aliment Pharmacol Ther
; 51(2): 244-252, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31769533
Resultados
1 -
3
de 3
1
Próxima >
>>